After sitting inside, fourth behind leaders Twirling Point and StayHot early, Mondego ($21.20) swung out and hit the front in the final furlong of the 1-1/4-mile race that started on the turf hillside.
With this milestone, Mondego Bio is transitioning into clinical-stage operations and plans to initiate a first-in-human (FIH) Phase 1 clinical study in the first half of 2026 ... About Mondego Bio ... SOURCE Mondego Bio.